Financial News
Lineage Cell Therapeutics Inc (NY: LCTX )
0.9481
+0.0560
(+6.28%)
Official Closing Price
Updated: 8:00 PM EDT, Aug 23, 2024
Add to My Watchlist
All News about Lineage Cell Therapeutics Inc
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/mid-day_movers_image_82.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/movers_image_3058.jpeg)
![](https://mms.businesswire.com/media/20220124005033/en/737852/5/LINEAGE_SCREEN_JPEG_1800x360.jpg)
![](https://mms.businesswire.com/media/20220104005219/en/737852/5/LINEAGE_SCREEN_JPEG_1800x360.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_354.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_2929.png)
![](https://investorplace.com/wp-content/uploads/2021/05/wall-street-morning.jpg)
![](https://mms.businesswire.com/media/20211220005028/en/737852/5/LINEAGE_SCREEN_JPEG_1800x360.jpg)
![](https://mms.businesswire.com/media/20211110006231/en/737852/5/LINEAGE_SCREEN_JPEG_1800x360.jpg)
![](https://mms.businesswire.com/media/20211130005471/en/737852/5/LINEAGE_SCREEN_JPEG_1800x360.jpg)
Lineage Reports Fourth Case of Retinal Tissue Restoration With OpRegen®
November 30, 2021
Via Business Wire
![](https://mms.businesswire.com/media/20211103005019/en/737852/5/LINEAGE_SCREEN_JPEG_1800x360.jpg)
![](https://mms.businesswire.com/media/20211115005451/en/737852/5/LINEAGE_SCREEN_JPEG_1800x360.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/daniil-kuzelev-qrawwgv6gmo-unsplash.jpg)
![](https://mms.businesswire.com/media/20211026005496/en/737852/5/LINEAGE_SCREEN_JPEG_1800x360.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2021/roce_image_950.jpeg)
![](https://mms.businesswire.com/media/20211018005115/en/737852/5/LINEAGE_SCREEN_JPEG_1800x360.jpg)
![](https://mms.businesswire.com/media/20210920005302/en/737852/5/LINEAGE_SCREEN_JPEG_1800x360.jpg)
![](https://mms.businesswire.com/media/20210930005305/en/911638/5/5296269_20210930_LCTX_OpRegen_Graph.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/mid-day_movers_image_18.jpg)
38 Stocks Moving In Wednesday's Mid-Day Session
September 15, 2021
Via Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/cells-1872666_1920_96.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_288.png)
53 Biggest Movers From Yesterday
September 16, 2021
Via Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
![](https://mms.businesswire.com/media/20210915005401/en/737852/5/LINEAGE_SCREEN_JPEG_1800x360.jpg)
![](https://mms.businesswire.com/media/20210913005252/en/737852/5/LINEAGE_SCREEN_JPEG_1800x360.jpg)
![](https://mms.businesswire.com/media/20210901005330/en/737852/5/LINEAGE_SCREEN_JPEG_1800x360.jpg)
Lineage Announces Appointment of General Counsel
September 01, 2021
Via Business Wire
![](https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template.jpg)
![](https://mms.businesswire.com/media/20210812005745/en/737852/5/LINEAGE_SCREEN_JPEG_1800x360.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/eye-1132531_640.jpg)
![](https://mms.businesswire.com/media/20210810005334/en/737852/5/LINEAGE_SCREEN_JPEG_1800x360.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/dna-24559_1280_41.png)
Via Benzinga
Exposures
Product Safety
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.